Incidence of Retinal Detachment, Macular Edema, and Ocular Hypertension after Neodymium:Yttrium-Aluminum-Garnet Capsulotomy: A Population-Based Nationwide Study-The French YAG 2 Study

Ophthalmology. 2023 May;130(5):478-487. doi: 10.1016/j.ophtha.2022.12.022. Epub 2022 Dec 26.

Abstract

Purpose: To estimate the incidence and assess the risk factors associated with 3 adverse events (AEs) after neodymium:yttrium-aluminum-garnet posterior capsulotomy (Nd:YAG-caps): ocular hypertension (OHT), macular edema (ME), and retinal detachment (RD).

Design: Observational cohort study using a nationwide claims database.

Participants: Adults who underwent Nd:YAG-caps between 2014 and 2017, with no ocular disease history in the year before.

Methods: Patients who underwent Nd:YAG-caps were identified using data from the French national representative sample and followed up for 12 months postprocedure. The time to AE was assessed using the Kaplan-Meier method. Factors associated with AE were assessed using Cox models.

Main outcome measures: Neodymium:YAG-caps epidemiology, patients' characteristics, proportion of patients with AE, and hazard ratios (HRs) associated with variables identified as factors associated with AEs.

Results: During the study period, 6210 patients received Nd:YAG-caps (7958 procedures). The mean age (± standard deviation) at Nd:YAG-caps was 75.0 (± 10.3) years. The 3-month and 12-month overall AE rates (≥ 1 AE of interest) were 8.6% and 13.3%, respectively. Among patients with ≥ 1 AE of interest, 68.4% of AEs occurred within 3 months post-Nd:YAG-caps. Three-month rates were ≈5% for OHT and ME. Retinal detachment remained ≤ 0.5% over follow-up. Cox models showed that patients with Nd:YAG-caps performed within 1 year after cataract surgery had a higher risk of AEs than those with later Nd:YAG-caps (hazard ratio [HR], 1.314 [1.034-1.669], P = 0.0256), notably ME (HR, 1.500 [1.087-2.070], P = 0.0137). Diabetic patients were more at risk of OHT (HR, 1.233 [1.005-1.513], P = 0.0448) and ME (HR, 1.810 [1.446-2.266], P < 0.0001) than nondiabetic patients. Patients with Nd:YAG-caps performed between 1 and 2 years after cataract surgery were more at risk of OHT than patients with later Nd:YAG-caps (HR, 1.429 [1.185-1.723], P = 0.0002).

Conclusions: According to a national claims database, OHT and ME were the most frequent AEs of interest post-Nd:YAG-caps, mainly observed within 3 months postprocedure, highlighting the need for a close follow-up during this period or a delayed capsulotomy. Diabetes and an early Nd:YAG-caps after cataract surgery were among the main drivers for AE occurrence.

Financial disclosure(s): Proprietary or commercial disclosure may be found after the references.

Keywords: Adverse events; Cataract; Data claims; Database; Nd:YAG; Ophthalmology; Risk factors.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Capsule Opacification* / epidemiology
  • Capsule Opacification* / etiology
  • Capsule Opacification* / surgery
  • Cataract Extraction* / adverse effects
  • Humans
  • Incidence
  • Laser Therapy* / adverse effects
  • Lens Capsule, Crystalline* / surgery
  • Macular Edema* / epidemiology
  • Macular Edema* / etiology
  • Middle Aged
  • Neodymium
  • Ocular Hypertension* / epidemiology
  • Ocular Hypertension* / etiology
  • Postoperative Complications / etiology
  • Retinal Detachment* / epidemiology
  • Retinal Detachment* / etiology
  • Retinal Detachment* / surgery

Substances

  • Neodymium
  • yttrium-aluminum-garnet